ResearcherNorthwestern UniversityNo recent work listed
Jia Ying Yang
Matched on ORCID iD 0000-0002-3992-4070; OpenAlex author ID A5101992142. Sources: OpenAlex.
Their work
- Papers
- 13 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2019: 5 papers · 2020: 6 papers · 2021: 2 papers
Papers 13
- Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI Radiomics: A Preliminary Inve… First author DOI 10.1016/j.acra.2020.04.026↗
- Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic canc… Co-author DOI 10.1080/2162402x.2021.1875638↗
- Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. Co-author DOI 10.1016/j.jcyt.2019.12.001↗
- MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma. First author DOI 10.1186/s12967-020-02246-7↗
- Contrast-enhanced CT radiomics for predicting lymph node metastasis in pancreatic ductal adenocarcinoma: a pilot study. Co-author DOI 10.1186/s40644-020-0288-3↗
- Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pancreatic ductal adenocarcinoma. Co-author PMID 32269732↗
- Prediction of therapeutic outcome and survival in a transgenic mouse model of pancreatic ductal adenocarcinoma treated with dendritic cell vaccination or CDK i… First author PMID 32509212↗
- Effect of route of administration on the efficacy of dendritic cell vaccine in PDAC mice. Co-author PMID 33294276↗
- Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies. Co-author DOI 10.1016/j.prp.2019.152691↗
- MRI Assessment of Associations between Brown Adipose Tissue and Cachexia in Murine Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.4172/2165-8048.1000301↗
- Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer models. Co-author PMID 30949410↗
- Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a Kras LSL-G12D p53LSL-R172H Pdx1-Cre mouse model. First author PMID 31497356↗
- Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma. Co-author PMID 31815046↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhuoli Zhang · 13 shared papers, 2019–2021 · strength 1.44
- Paper Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multipara… DOI 10.1016/j.acra.2020.04.026↗
- Paper Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccin… DOI 10.1080/2162402x.2021.1875638↗
- Paper Effect of route of administration on the efficacy of dendritic cell vaccine in PDAC mice. PMID 33294276↗
- Vahid Yaghmai · 11 shared papers, 2019–2021 · strength 1.24
- Paper Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multipara… DOI 10.1016/j.acra.2020.04.026↗
- Paper Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccin… DOI 10.1080/2162402x.2021.1875638↗
- Paper Effect of route of administration on the efficacy of dendritic cell vaccine in PDAC mice. PMID 33294276↗
- Aydın Eresen · 10 shared papers, 2019–2021 · strength 1.18
- Paper Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multipara… DOI 10.1016/j.acra.2020.04.026↗
- Paper Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccin… DOI 10.1080/2162402x.2021.1875638↗
- Paper Effect of route of administration on the efficacy of dendritic cell vaccine in PDAC mice. PMID 33294276↗
- Al B. Benson · 5 shared papers, 2019–2021 · strength 0.57
- Paper Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multipara… DOI 10.1016/j.acra.2020.04.026↗
- Paper Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pa… PMID 32269732↗
- Paper Prediction of therapeutic outcome and survival in a transgenic mouse model of pancreatic ductal adenocarcinoma treated … PMID 32509212↗
- Su Hu · 4 shared papers, 2019–2020 · strength 0.38
- Paper Prediction of therapeutic outcome and survival in a transgenic mouse model of pancreatic ductal adenocarcinoma treated … PMID 32509212↗
- Paper MRI Assessment of Associations between Brown Adipose Tissue and Cachexia in Murine Pancreatic Ductal Adenocarcinoma. DOI 10.4172/2165-8048.1000301↗
- Paper Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a Kras LSL-G12D p53LS… PMID 31497356↗
- Liang Pan · 4 shared papers, 2019–2020 · strength 0.36
- Paper Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. DOI 10.1016/j.jcyt.2019.12.001↗
- Paper MRI Assessment of Associations between Brown Adipose Tissue and Cachexia in Murine Pancreatic Ductal Adenocarcinoma. DOI 10.4172/2165-8048.1000301↗
- Paper Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma. PMID 31815046↗
- Su Hu · 3 shared papers, 2020 · strength 0.32
- Paper Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pa… PMID 32269732↗
- Paper MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal aden… DOI 10.1186/s12967-020-02246-7↗
- Paper Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. DOI 10.1016/j.jcyt.2019.12.001↗
- Yaqi Zhang · 2 shared papers, 2019 · strength 0.17
- Yumin Li · 1 shared paper, 2020 · strength 0.11
- Anna Junjie Shangguan · 1 shared paper, 2020 · strength 0.10
- Jingjing Xiao · 1 shared paper, 2020 · strength 0.09
- Ke Li · 1 shared paper, 2020 · strength 0.09
- Lian Li · 1 shared paper, 2020 · strength 0.09
- Wei Chen · 1 shared paper, 2020 · strength 0.09
- Li Yu · 1 shared paper, 2019 · strength 0.09
- Su Hu · 1 shared paper, 2019 · strength 0.09
- Wei Xing · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.